Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at THB 3.19T, ahead of Eli Lilly (THB 2.21T) and Merck & Co (THB 2.2T). Figures as of 20 Nov 2026, 09:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonTHB 3.19T
- Median
- THB 108.6B
- Combined market value
- THB 168.27T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | THB 3.19T | THB 21.81T | THB 9,058.72 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | THB 2.21T | THB 40.81T | THB 45,816.48 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | THB 2.2T | THB 11.1T | THB 4,503.59 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | THB 2.12T | THB 5.32T | THB 933.88 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | THB 2.07T | THB 17T | THB 9,614.84 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | THB 1.99T | THB 9.23T | THB 5,948.15 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | THB 1.85T | THB 9.68T | THB 5,127.87 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | THB 1.64T | THB 3.75T | THB 1,561.89 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | THB 1.63T | THB 4.04T | THB 1,978.31 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | THB 1.56T | THB 5.81T | THB 1,318.08 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | THB 1.5T | THB 6.1T | THB 3,522.23 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | THB 1.47T | THB 3.25T | THB 1,621.58 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | THB 956.9B | THB 2.32T | THB 726.01 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | THB 585.2B | THB 1.52T | THB 1,306.89 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | THB 486.4B | THB 3.24T | THB 31,310.46 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | THB 484.9B | THB 772.9B | THB 674.13 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | THB 407B | THB 4.48T | THB 17,655.58 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | THB 321B | THB 1.11T | THB 2,739.59 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | THB 283.1B | THB 189.2B | THB 278.06 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | THB 181.2B | THB 1.55T | THB 13,553.83 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | THB 159.9B | THB 445.6B | THB 891.49 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | THB 144.7B | THB 514.7B | THB 8,018.02 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | THB 126.1B | THB 1.07T | THB 1,741.28 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | THB 125.9B | THB 671.4B | THB 5,012.58 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | THB 121.2B | THB 419.2B | THB 502.89 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | THB 109.2B | THB 403.4B | THB 2,082.75 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | THB 107.9B | THB 807.4B | THB 18,959.08 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | THB 102.4B | THB 252.7B | THB 725.33 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | THB 80.6B | THB 1.32T | THB 2,296.39 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | THB 58.7B | THB 165.2B | THB 1,977.80 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | THB 50B | THB 263.2B | THB 1,565.96 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | THB 34.9B | THB 105.9B | THB 545.95 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | THB 32.5B | THB 312.5B | THB 13,453.45 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | THB 32B | THB 153.7B | THB 923.03 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | THB 28.1B | THB 209.2B | THB 1,480.17 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | THB 27.1B | THB 569.3B | THB 8,679.60 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | THB 25.8B | THB 241.2B | THB 2,203.47 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | THB 23B | THB 249.2B | THB 3,171.77 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | THB 21.7B | THB 242B | THB 4,600.91 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | THB 20.9B | THB 332.5B | THB 2,200.08 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | THB 20.6B | THB 1.07T | THB 4,898.64 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | THB 17.7B | THB 211.4B | THB 3,238.74 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | THB 17B | THB 516.4B | THB 2,651.08 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | THB 16.6B | THB 157.2B | THB 1,637.85 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | THB 9.1B | THB 194.6B | THB 9,730.14 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | THB 6.4B | THB 274.6B | THB 3,960.69 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | THB 3B | THB 243.1B | THB 1,745.01 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | THB 1.6B | THB 274.5B | THB 4,205.52 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | THB 280.1M | THB 957.2B | THB 1,321.13 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | THB 69M | THB 162B | THB 2,876.59 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | THB 0 | THB 314.4B | THB 3,310.63 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | THB 0 | THB 294.7B | THB 10,542.62 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9100 THB). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (THB 3.19T), Eli Lilly (THB 2.21T) and Merck & Co (THB 2.2T) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 09:40 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of THB 168.27T as of 20 Nov 2026, 09:40 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.